OTC · Financial Statements
Genix Pharmaceuticals Corporation (GENPF) Financial Statements
$0.01
OTC: GENPF
Market Cap $844893
Overview Financials Dividend Genix Pharmaceuticals Corporation most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-2.0M $-1.0M $-1.0M $0 $0 Net Profit $-2.0M $-1.0M $-4.0M $0 $0 EPS $-0.03 $-0.02 $-0.07 $0.00 $-0.01 Op Margin — — -7134.5% -5949.2% —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $5.0M $4.0M $0 $0 $0 Total Liabilities $1.0M $1.0M $1.0M $1.0M $1.0M Cash $0 $0 $0 $0 $0 Borrowings $0 $0 $1.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $0 $0 $0 $0 $0 Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $-1.0M $0 $0 $0 $0 Free Cash Flow $0 $0 $0 $0 $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.01 EV / EBITDA -16.83 FCF Yield -7.51% Quick Ratio 0.02 Interest Coverage -0.68 Return 1Y 0.00% Return 3Y -69.60% Return 5Y —
Screens featuring this stock